Jones, Sarah <br/><br/>
Targeted treatment for lung cancer could be  possible due to identification of nonuniform genetic  mutations.  [electronic resource] 

 -  Pharmacogenomics  May 2014 
 - 903-4 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1744-8042 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Mutation<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>ras Proteins--genetics